Regardless of their relevance or genius, 95% of all healthtech inventions never reach the market, while bringing them to the patient could significantly improve many lives around the world. This stunning realisation led CEO and founder Bert-Arjan Millenaar to embark on NLC’s journey to find inventions, select the best ones and build them into viable healthtech ventures.
5 years on, NLC has evaluated hundreds of inventions, built over 80 ventures, and plans to build many more in the years to come with our great team of dedicated employees and industry experts.
Together we are building ventures and advancing health for patients around the world, every day.
Entrepreneurship at scale
We strongly believe the only way in succeeding to bring more healthtech inventions to the patient, is by using entrepreneurship at scale. Entrepreneurship is essential to get a venture through the early stages, where you really need to put in the hard graft and work on many levels at the same time. The dedication of the CEO’s and their team are pivotal to getting their venture to the market successfully.
And by building ventures at scale, we can benefit from data and learnings we’ve harvested along the way. To support a venture, we build teams around it that know what it takes to make a venture successful. We know the pitfalls and the shortcuts, we try hard, and if we fail, we fail fast. We surround our CEO’s with expertise and support, from helping to secure finance, to advice on patents and certifications, to training the team on Sales – and everything in between.
Our network is hugely important to us. Throughout our venture building process, our team is supported by dedicated specialists from around the world. Inventors and research institutes that want to bring their invention to the market with us, medical, technical and business specialists that help us evaluate the inventions, investors that are willing to take the risk and invest in early seed start-ups, and entrepreneurs and advisors that help us grow the ventures we have build.
Together, we try to overcome the fragmentation, so we can build ventures and advance health.
The risk curve
NLC operates in the beginning of the risk curve where the risk is high and the invested capital is low. This creates an opportunity for us to make an impact in this space by utilising our entrepreneurships at scale to lower the risk curve of NLC’s individual ventures, to de-risk these ventures faster at low(er) cost and to scale NLC’s portfolio to further (statistically) de-risk our model.
“I have been working with NLC for a couple of years. From the first moment, NLC saw opportunities where I didn’t. Without the expertise and commitment of NLC, Nico.lab simply wouldn’t exist and we wouldn’t be able to help stroke patients this day.”
Certified B Corporation
NLC is extremely proud to be a Certified B Corporation since 2020. The non-profit company B Lab established that we meet their rigorous standards of social and environmental performance, accountability, and transparency.
Every day, NLC is dedicated to advancing health and making it accessible to everyone in a sustainable way. Therefore, the standards to qualify as a B Corp match the company’s DNA perfectly. Our company and our way of working are built around bringing together the best tech and the best people – both our own team of employees and our extensive network of specialists – to build ventures that can have a huge impact on the health of people around the world.
Sustainable Development Goals
The 17 Sustainable Development Goals (SDGs) were set up in 2015 by United Nations and are intended to be achieved by 2030. The interlinked global goals provide a shared blueprint for peace and prosperity for people and the planet, now and into the future.
All our decisions at NLC are made with the aim to make a positive impact on people and our planet. We do this every day when building ventures to advance health.